688505.SS
Price:
$7.93
Market Cap:
$911.28M
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd., together with its associated entities, specializes in the research, development, production, and commercialization of cutting-edge biopharmaceutical products. The company's extensive pipeline is built upon several advanced technological platforms. Its genetic engineering platform prominently features antibody-drug conjugates (ADCs), with candidates like CD30-DM1 ADC and Trop2-SN38 ADC currently undergoing Phase I clinical trials for a range of tumors, including triple-negative breast, bladder, and gastric cancers. Additional ADCs, such as Trop2-BB05 (targeting lung cancer and triple-negative breast cancer) and HER2 ADC (for metastatic b...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2020-06-19
Stock Exchange
SHH
Ticker
688505.SS
According to Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd.’s latest financial reports and current stock price. The company's current PE Ratio is -131.14. This represents a change of -154.65% compared to the average of 239.94 of the last 4 quarters.
The mean historical PE Ratio of Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. over the last ten years is 162.11. The current -131.14 PE Ratio has changed -8189.73% with respect to the historical average. Over the past ten years (40 quarters), 688505.SS's PE Ratio was at its highest in in the March 2024 quarter at 857.61. The PE Ratio was at its lowest in in the March 2020 quarter at -462.50.
Average
162.11
Median
124.85
Minimum
-55.33
Maximum
453.43
Discovering the peaks and valleys of Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 140.49%
Maximum Annual PE Ratio = 453.43
Minimum Annual Increase = -127.63%
Minimum Annual PE Ratio = -55.33
| Year | PE Ratio | Change |
|---|---|---|
| 2025 | -55.33 | -127.63% |
| 2024 | 200.26 | 140.49% |
| 2023 | 83.27 | 29.65% |
| 2022 | 64.23 | -8.89% |
| 2021 | 70.50 | -30.68% |
| 2020 | 101.71 | -31.28% |
| 2019 | 148.00 | -52.00% |
| 2018 | 308.33 | -32.00% |
| 2017 | 453.43 | 83.82% |
| 2016 | 246.67 | -6.67% |
The current PE Ratio of Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. (688505.SS) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
76.07
5-year avg
72.59
10-year avg
162.11
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd.’s PE Ratio is less than Changjiang Pharmaceutical Group Co., Ltd. (-0.32), less than JiangSu WuZhong Pharmaceutical Development Co., Ltd. (-2.33), less than Suzhou Iron Technology CO.,LTD (188.56), less than Tiansheng Pharmaceutical Group Co., Ltd. (-32.27), less than Shaanxi Kanghui Pharmaceutical Co., Ltd. (-12.21), less than Shenzhen GuoHua Network Security Technology Co.,Ltd. (6.24), less than Chengdu Huasun Technology Group Inc., Ltd. (-8.38), less than Anhui Huangshan Capsule Co., Ltd. (30.91), less than Zhejiang Xinguang Pharmaceutical Co., Ltd. (41.52), greater than Guangdong Lifestrong Pharmacy Co., Ltd. (-685.22),
| Company | PE Ratio | Market cap |
|---|---|---|
| -0.32 | $66.56M | |
| -2.33 | $206.16M | |
| 188.56 | $1.56B | |
| -32.27 | $1.70B | |
| -12.21 | $3.63B | |
| 6.24 | $67.51M | |
| -8.38 | $2.56B | |
| 30.91 | $1.98B | |
| 41.52 | $2.28B | |
| -685.22 | $3.19B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd.'s PE Ratio?
How is the PE Ratio calculated for Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. (688505.SS)?
What is the highest PE Ratio for Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. (688505.SS)?
What is the 3-year average PE Ratio for Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. (688505.SS)?
What is the 5-year average PE Ratio for Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. (688505.SS)?
How does the current PE Ratio for Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. (688505.SS) compare to its historical average?